Relmada Therapeutics, Inc. RLMD Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $3.5M-9.3% | $3.86M-5.7% | $4.09M-24.2% | $5.4M-87.9% | ||
| $89.51M+118% | $41.05M-55.5% | $92.23M-35.5% | $142.93M-14.7% | ||
| $93.98M+105% | $45.8M-53.0% | $97.51M-36.2% | $152.87M-31.5% | ||
| $3.54M+67.1% | $2.12M-18.5% | $2.6M— | —— | ||
| $94M+105% | $45.82M-53.0% | $97.55M-36.2% | $152.91M-31.5% | ||
| $1.57M-62.0% | $4.13M+17.8% | $3.51M-33.4% | $5.26M-53.0% | ||
| $6.43M-37.5% | $10.29M-15.6% | $12.19M-2.2% | $12.47M-17.2% | ||
| $7.49M-27.2% | $10.3M-15.6% | $12.19M-2.2% | $12.47M-17.2% | ||
| 150M0.0% | 150M0.0% | 150M0.0% | 150M0.0% | ||
| -$698.27M-9.0% | -$640.88M-14.3% | -$560.9M-21.4% | -$462.11M-51.5% | ||
| $86.51M+144% | $35.52M-58.4% | $85.36M-39.2% | $140.44M-32.6% | ||
| $94M+105% | $45.82M-53.0% | $97.55M-36.2% | $152.91M-31.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Relmada Therapeutics, Inc.'s total assets?
- Relmada Therapeutics, Inc. (RLMD) holds $235.4M in total assets, up 750.3% year over year.
- How much cash does Relmada Therapeutics, Inc. have?
- Relmada Therapeutics, Inc. holds $9.8M in cash and equivalents.
- Can Relmada Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 18.26 — current assets exceed current liabilities.
- Where does Relmada Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Relmada Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.